Zobrazeno 1 - 10
of 47
pro vyhledávání: '"W. Rossbach"'
Autor:
Klaus Mann, Matthias J. Müller, Joachim Röschke, Otto Benkert, Florian Müller-Siecheneder, Hermann Wetzel, M Blümler, W. Rossbach, Ralf W. Dittmann, H. Russ
Publikováno v:
Pharmacopsychiatry. 37:157-162
Background It is well known that sleep disturbance is an integral symptom of schizophrenia. In recent studies, a deficit of delta sleep has been observed in schizophrenic patients. Antipsychotic drugs with serotonin (5-HT2) receptor-antagonistic prop
Publikováno v:
Psychoneuroendocrinology. 25:377-388
To evaluate the subchronic effects of paroxetine, a selective serotonin reuptake inhibitor, on nocturnal endocrinological profiles, eight healthy male volunteers with no personal or family history of a psychiatric or neurological disease were adminis
Publikováno v:
Der Nervenarzt. 71:195-204
Die vorliegende Arbeit umfasst 3 Untersuchungen zur Interrater-Reliabilitat der deutschen Version der “Positive and Negative Syndrome Scale for Schizophrenia” (PANSS). Zur Interrater-Reliabilitat und Trainierbarkeit der PANSS liegen im deutschen
Autor:
Florian Müller-Siecheneder, W. Rossbach, Armin Szegedi, Matthias J. Müller, Hermann Wetzel, Petra Dannigkeit
Publikováno v:
Schizophrenia Research. 32:151-160
The Positive and Negative Syndrome Scale (PANSS) is employed increasingly for the evaluation of therapeutic outcome in studies on schizophrenia. Rater training is important to improve the concordance and accuracy of ratings; however, there are no est
Autor:
Ralf G.M. Schlösser, P. Kögel, Otto Benkert, Klaus Mann, W. Rossbach, P. Wagner, Joachim Röschke
Publikováno v:
Psychopharmacology. 132:44-49
Paroxetine is a selective and potent serotonin reuptake inhibitor and its efficacy for the treatment of depression has been proven. Under acute and subchronical treatment regimens, disturbances of the regular sleep pattern are a reported side effect
Autor:
Florian Müller-Siecheneder, Tobias Pott, W. Rossbach, Iris Linde, Matthias J. Müller, Christoph Hiemke, Klaus Mann, Ralf W. Dittmann
Publikováno v:
Psychoneuroendocrinology. 31(2)
Summary Nocturnal hormone profiles were measured in patients with schizophrenia with predominantly negative symptoms both under drug-free baseline conditions and after subchronic administration of the atypical antipsychotic olanzapine, with the aim o
Autor:
Klaus Mann, H. Wetzel, Joachim Röschke, Matthias J. Müller, Ralf W. Dittmann, H. Russ, O. Benkert, Florian Müller-Siecheneder, W. Rossbach
Publikováno v:
6. Bad Homburger ZNS-Gespräche ISBN: 9783540001393
Moderne Antipsychotika verbessern sowohl die Positiv- als auch die Negativsymptomatik. Die vorliegende Studie vergleicht die klinische Wirksamkeit einer Therapie mit Olanzapin bei Patienten mit uberwiegender Positiv- oder Negativsymptomatik [1].
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85126b8cd48717f42558cc22fa98b093
https://doi.org/10.1007/978-3-662-05556-4_18
https://doi.org/10.1007/978-3-662-05556-4_18
Publikováno v:
Der Nervenarzt. 71(3)
The present analysis comprises 3 studies on the interrater reliability of the Positive and Negative Syndrome Scale for Schizophrenia (PANSS; German version). To our knowledge this is the first empirical report on interrater reliability and on results
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 8(4)
Paroxetine is a selective and potent serotonin reuptake inhibitor with reported antidepressant properties. Since changes in the regular sleeping pattern were described as side effects under treatment with paroxetine, the impact of the drug on the sle
Autor:
Goran Vucurevic, Peter Stoeter, Ralf G.M. Schlösser, Bettina Kaufmann, Th. Gesierich, Stefan Hunsche, J. Gawehn, W. Rossbach
Publikováno v:
NeuroImage. 11:S220